Dosage forms and methods for oral delivery of progesterone

Details Dosage forms and methods for oral delivery of progesterone Dosage forms and methods for oral delivery of progesterone

2005-03-15

2005-03-15

Page, Thurman K. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

C424S464000, C424S467000, C424S489000

Reexamination Certificate

active

06866865

ABSTRACT:
Oral progesterone unit dosage forms comprising micronized progesterone and a solid polymeric carrier are provided. The dosage forms, upon oral administration, provide a therapeutically effective blood level of progesterone to a subject. The therapeutically effective blood level of progesterone may range from about 0.1 ng/ml to about 400 ng/ml. The dosage forms can be prepared for immediate as well as sustained release. The oral progesterone dosage form can be combined with an estrogen dosage form to provide combination hormone therapy.

REFERENCES:
patent: 2032827 (1936-03-01), Andrews
patent: 3432592 (1969-03-01), Speiser
patent: 4018388 (1977-04-01), Andrews
patent: 4629621 (1986-12-01), Snipes
patent: 4744976 (1988-05-01), Snipes et al.
patent: 4774074 (1988-09-01), Snipes
patent: 4801460 (1989-01-01), Goertz et al.
patent: 4806337 (1989-02-01), Snipes et al.
patent: 5004601 (1991-04-01), Snipes
patent: 5082655 (1992-01-01), Snipes et al.
patent: 5116619 (1992-05-01), Greco et al.
patent: 5140021 (1992-08-01), Maxson et al.
patent: 5518730 (1996-05-01), Fuisz
patent: 5543150 (1996-08-01), Bologna et al.
patent: 5877216 (1999-03-01), Place et al.
patent: 6077531 (2000-06-01), Salin-Drouin
patent: 6086916 (2000-07-01), Agnus et al.
patent: 6117446 (2000-09-01), Place
patent: 6117450 (2000-09-01), Dittgen et al.
patent: WO 9505807 (1995-03-01), None
patent: WO 9505807 (1995-03-01), None
patent: WO 9746242 (1997-12-01), None
patent: WO 9945932 (1999-09-01), None
Budavari et al., “The Merk Index: An Encyclopedia of Chemicals, Drugs, and Biologicals,” 12th Edition, Merck & Co., Inc., White House Station, NJ., (1996), pp. 1335-1336.
Cuff et al., “A Preliminary Evaluation of Injection Molding as a Technology to Produce Tablets,” Pharmaceutical Technol., Jun. 1998, pp. 96-106.
De Lignieres, “Oral Micronized Progesterone,” Cilia. Ther., (1999), vol. 21 (I), pp. 41-60.

Affiliated with

Also associated with

Rating

Dosage forms and methods for oral delivery of progesterone does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dosage forms and methods for oral delivery of progesterone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dosage forms and methods for oral delivery of progesterone will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3440101